ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients
- PMID: 30284039
- DOI: 10.1007/s00520-018-4464-y
ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients
Abstract
Chemotherapy-induced nausea and vomiting (CINV) is a common toxicity that may impair the quality of life of patients with a variety of early- and end-stage malignancies. In light of recent changes in the optimal management of CINV, we undertook this narrative review to compare the latest guidelines published by ASCO (2017), NCCN (2018), and MASCC/ESMO (2016). The processes undertaken by each organization to evaluate existing literature were also described. Although ASCO, NCCN, and MASCC/ESMO guidelines for the treatment and prevention of CINV share many fundamental similarities, literature surrounding low and minimal emetic risk regimens is lacking. Data regarding the use of complementary alternative medicine for CINV is particularly scarce and in need of further investigation.
Keywords: Antiemetic; Chemotherapy-induced nausea and vomiting; Guidelines; Prophylaxis.
Similar articles
-
2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients.Support Care Cancer. 2024 Apr 10;32(5):280. doi: 10.1007/s00520-024-08462-x. Support Care Cancer. 2024. PMID: 38594320 Review.
-
Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines.Support Care Cancer. 2019 Mar;27(3):783-791. doi: 10.1007/s00520-018-4586-2. Epub 2019 Jan 3. Support Care Cancer. 2019. PMID: 30607675 Review.
-
International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice.Eur J Pharmacol. 2014 Jan 5;722:197-202. doi: 10.1016/j.ejphar.2013.09.073. Epub 2013 Oct 21. Eur J Pharmacol. 2014. PMID: 24157984 Review.
-
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.Ann Hematol. 2020 Apr;99(4):867-875. doi: 10.1007/s00277-020-03945-3. Epub 2020 Feb 8. Ann Hematol. 2020. PMID: 32036421
-
[Emetogenic potential of antineoplastic agents based on clinical trials in Japan].Gan To Kagaku Ryoho. 2015 Mar;42(3):335-41. Gan To Kagaku Ryoho. 2015. PMID: 25812503 Japanese.
Cited by
-
The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials.Pharmaceuticals (Basel). 2022 Jan 14;15(1):100. doi: 10.3390/ph15010100. Pharmaceuticals (Basel). 2022. PMID: 35056154 Free PMC article. Review.
-
[Aldehyde dehydrogenase 2 rs671 genetic polymorphisms are associated with chemotherapy-induced nausea and vomiting].Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jun 20;43(6):1017-1022. doi: 10.12122/j.issn.1673-4254.2023.06.18. Nan Fang Yi Ke Da Xue Xue Bao. 2023. PMID: 37439175 Free PMC article. Chinese.
-
Personalized Prophylactic Antiemetic Regimens for Control of Chemotherapy-Induced Nausea and Vomiting by Pharmacogenetic Analysis of Three Receptor Genes: HTR3A, HTR3B, TACR1.JCO Precis Oncol. 2025 Apr;9:e2400858. doi: 10.1200/PO-24-00858. Epub 2025 Apr 18. JCO Precis Oncol. 2025. PMID: 40249884 Free PMC article.
-
Managing Side Effects of Cytotoxic Chemotherapy in Patients With High Grade Gliomas.Brain Tumor Res Treat. 2022 Jul;10(3):158-163. doi: 10.14791/btrt.2022.0018. Brain Tumor Res Treat. 2022. PMID: 35929113 Free PMC article. Review.
-
MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patients.Support Care Cancer. 2024 May 10;32(6):335. doi: 10.1007/s00520-024-08543-x. Support Care Cancer. 2024. PMID: 38727834
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical